Cargando…

Retraction: Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070914/ https://www.ncbi.nlm.nih.gov/pubmed/35511798 http://dx.doi.org/10.1371/journal.pone.0268357

Ejemplares similares

Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
por: Hojjat-Farsangi, Mohammad, et al.
Publicado: (2013)

Tyrosine Kinase ROR1 as a Target for Anti-Cancer Therapies
por: Zhao, Yuming, et al.
Publicado: (2021)

Construction and Stable Expression of a Truncated Human Receptor Tyrosine Kinase Ror1 (Ror1-ECD)
por: Forouzesh, Flora, et al.
Publicado: (2012)

Therapeutic Potential and Challenges of Targeting Receptor Tyrosine Kinase ROR1 with Monoclonal Antibodies in B-Cell Malignancies
por: Yang, Jiahui, et al.
Publicado: (2011)

Monoclonal Antibody Against ROR1 Induces Apoptosis in Human Bladder Carcinoma Cells
por: Bayat, Ali-Ahmad, et al.
Publicado: (2020)

Extracellular vesicle-associated tyrosine kinase-like orphan receptors ROR1 and ROR2 promote breast cancer progression
por: Irmer, Barnabas, et al.
Publicado: (2023)

Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains
por: Bainbridge, Travis W., et al.
Publicado: (2014)

Retraction: Long non-coding RNA ROR1-AS1 incudes tumorigenesis of colorectal cancer by affecting Wnt/β-catenin signaling pathway
Publicado: (2020)

ROR1 and ROR2 expression in pancreatic cancer
por: Liu, Dongli, et al.
Publicado: (2021)

The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells
por: Liu, Dongli, et al.
Publicado: (2022)

RORα and RORγ expression inversely correlates with human melanoma progression
por: Brożyna, Anna A., et al.
Publicado: (2016)

RETRACTION NOTICE: Skullcapflavone I protects cardiomyocytes from hypoxia-caused injury through up-regulation of lincRNA-ROR
Publicado: (2021)

The receptor tyrosine kinase Ror is required for dendrite regeneration in Drosophila neurons
por: Nye, Derek M. R., et al.
Publicado: (2020)

The Orphan Tyrosine Kinase Receptor, ROR2, Mediates Wnt5A Signaling in Metastatic Melanoma
por: O’Connell, Michael P., et al.
Publicado: (2009)

ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy
por: Rebagay, Guilly, et al.
Publicado: (2012)

The Tyrosine Kinase Receptor ROR1 Is Constitutively Phosphorylated in Chronic Lymphocytic Leukemia (CLL) Cells
por: Hojjat-Farsangi, Mohammad, et al.
Publicado: (2013)

Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia
por: Hojjat-Farsangi, Mohammad, et al.
Publicado: (2015)

Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies
por: Dave, Hema, et al.
Publicado: (2012)

Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)
por: Jeong, Soo Young, et al.
Publicado: (2022)

Retracted: A Nanoparticle-Conjugated Anti-TBK1 siRNA Induces Autophagy-Related Apoptosis and Enhances cGAS-STING Pathway in GBM Cells
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

New insights into the molecular mechanisms of ROR1, ROR2, and PTK7 signaling from the proteomics and pharmacological modulation of ROR1 interactome
por: Raivola, Juuli, et al.
Publicado: (2022)

Digoxin, an Overlooked Agonist of RORγ/RORγT
por: Karaś, Kaja, et al.
Publicado: (2019)

Retracted: lncRNA-SNHG14 Promotes Atherosclerosis by Regulating RORα Expression through Sponge miR-19a-3p
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Pan-Tissue and -Cancer Analysis of ROR1 and ROR2 Transcript Variants Identify Novel Functional Significance for an Alternative Splice Variant of ROR1
por: John, Miya, et al.
Publicado: (2022)

Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C E, et al.
Publicado: (2016)

Receptor tyrosine kinase profiling of ischemic heart identifies ROR1 as a potential therapeutic target
por: Heliste, Juho, et al.
Publicado: (2018)

Inhibition of heat shock protein 90 destabilizes receptor tyrosine kinase ROR1 in lung adenocarcinoma
por: Khaledian, Behnoush, et al.
Publicado: (2021)

Retracted: Lentivirus-Mediated siRNA Targeting ER-α Inhibits Tumorigenesis and Induces Apoptosis in Hepatocarcinoma Cells
por: International, BioMed Research
Publicado: (2020)

Anti-ROR1 CAR-T cells: Architecture and performance
por: Osorio-Rodríguez, Daniel Andrés, et al.
Publicado: (2023)

Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells
por: Yin, Zhengna, et al.
Publicado: (2017)

A ROR1 small molecule inhibitor (KAN0441571C) induced significant apoptosis of ibrutinib‐resistant ROR1(+) CLL cells
por: Ghaderi, Amineh, et al.
Publicado: (2021)

Correction to: Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
por: Henry, C. E., et al.
Publicado: (2022)

ROR1: an orphan becomes apparent
por: Kipps, Thomas J.
Publicado: (2022)

Crystal structure of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (hROR1)
por: Guarino, Salvatore R., et al.
Publicado: (2022)

Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia
por: Yikilmaz, Aysun Şentürk, et al.
Publicado: (2023)

Comparative Expression Profile of Orphan Receptor Tyrosine Kinase ROR1 in Iranian Patients with Lymphoid and Myeloid Leukemias
por: Shabani, Mahdi, et al.
Publicado: (2011)

Statement of Retraction: Regulation function of MMP-1 downregulated by siRNA on migration of heat-denatured dermal fibroblasts
Publicado: (2020)

High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia
por: Ghia, Emanuela M., et al.
Publicado: (2022)

Retraction notice for: “Long non-coding RNA-ROR aggravates myocardial ischemia/reperfusion injury” [Braz J Med Biol Res (2018) 51(6): e6555]
Publicado: (2021)

ROR2, a driver of “phenotype switching” in melanoma?
por: Lopez-Bergami, Pablo
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_36dac5d1tb7591cphv1rjt4ec4